Brief: Clearside Biomedical Completes Recruitment In ODYSSEY Phase 2b Clinical Trial Of CLS-AX In Wet AMD
01/11/2023 11:13
Nov 1 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL COMPLETES RECRUITMENT IN ODYSSEY
PHASE 2B
CLINICAL TRIAL OF CLS-AX IN WET AMD
* CLEARSIDE BIOMEDICAL INC - TOPLINE DATA EXPECTED IN Q3
2024
Source text for Eikon: ID:nGNX2H4GF4
Further company coverage: CLSD.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials